Sign in
CompletedNo phase

Sedation Depth and EGJ Endoscopic Grading: A Randomized Controlled Trial

Key facts

Who runs it
Mohamed Abd El-Raouf Tawfik
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
192 people enrolled
Started
1 Jun 2026
Ended
30 Sept 2026
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Upper gastrointestinal endoscopy
Record updated
23 October 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Brief Study Summary:

Read full original descriptionShow less

This prospective randomized controlled trial evaluates the impact of procedural sedation depth on the American Foregut Society (AFS) endoscopic grading of esophagogastric junction (EGJ) integrity and its correlation with objective gastroesophageal reflux disease (GERD) severity. A total of 192 adult patients undergoing diagnostic upper endoscopy were randomly allocated across three active sedation arms (Mild, Moderate, and Deep Sedation). Using a dual assessment protocol, AFS grades were recorded before and after sedation to assess how suppressing neuromuscular reflex tone unmasks underlying structural EGJ incompetence, with results correlated against baseline validated GerdQ scores, Los Angeles esophagitis grades, and 24-hour ambulatory pH-impedance monitoring.

The 3 groups in the trial

  • Mild sedationExisting treatment, for comparison

    Propofol titration targeting an Observer's Assessment of Alertness/Sedation (MOAA/S) score of 4.

    Treatment: Upper gastrointestinal endoscopy

  • Moderate sedationExisting treatment, for comparison

    Propofol plus intermittent fentanyl titration targeting an MOAA/S score of 2-3.

    Treatment: Upper gastrointestinal endoscopy

  • Deep sedationExisting treatment, for comparison

    Propofol plus dexmedetomidine infusion targeting an MOAA/S score of 1-2.

    Treatment: Upper gastrointestinal endoscopy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Unmasking Esophagogastric Junction Dysfunction: Effect of Anesthesia Depth on AFS-Based Endoscopic Assessment and GERD Severity
Record updated
23 October 2026